In addition, a high significant hazard ratio for GCG expression was noted as associated with the type of primary tumor response (HR = 9.2, p < 0.001), and future studies should analyze relevant functional mechanisms underpinning these differences and investigate the role of GCG-related signaling in tumor responsiveness. The gene discussed is GCG; the disease is neoplasm.